FindMyClinicalTrial Inc. Collaborates With Mayo Clinic on Clinical Trial Software

WASHINGTON, DC / ACCESSWIRE / June 17, 2024 / FindMyClinicalTrial Inc. (FMCT), a digital health startup company building patient engagement and recruitment solutions for clinical trials, today announced a know-how agreement with Mayo Clinic to continue and finalize the development of FMCT’s clinical trial platforms for patients, health centers, and research sites.

FMCT Logo
FindMyClinicalTrial Logo

Clinical trials are crucial for advancing medical knowledge and bringing new treatments to patients. However, patient recruitment and engagement remain major challenges, with up to 80% of trials delayed or terminated due to enrollment difficulties. FMCT takes a community-driven approach by building its software around facilitating engagement between trial teams, health centers, and patient communities.

“We are excited to collaborate with Mayo Clinic,” said Killian Lozach, CEO of FMCT. “Together, we aim to transform how patients connect with and participate in clinical trials by empowering them with education, community support, and seamless digital experiences.”

The collaboration aims to leverage Mayo Clinic’s extensive clinical trial expertise and FMCT’s cutting-edge technology to develop a patient-centric platform that streamlines recruitment, enhances engagement, and improves retention throughout the clinical trial journey.

Mayo Clinic has a financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education, and research.

Contact Information

Emma Briggs
Vice President – Strategic Alliances
emma.briggs@findmyclinicaltrial.org

Killian Lozach
CEO & Founder
killian.lozach@findmyclinicaltrial.org
8583365157

SOURCE: FindMyClinicalTrial Inc.

View the original press release on newswire.com.

View the original press release on accesswire.com

Staff

Recent Posts

MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics

GENEVA, SWITZERLAND / ACCESS Newswire / December 23, 2025 / MindMaze Therapeutics Holding SA (SIX:MMTX…

2 hours ago

MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics

GENEVA, SWITZERLAND / ACCESS Newswire / December 23, 2025 / MindMaze Therapeutics Holding SA (SIX:MMTX…

2 hours ago

MindHYVE.ai™ and KPSIAJ Sign Strategic MOU to Advance AI-Driven Innovation in Education and Healthcare Across Karachi

KARACHI, Pakistan, Dec. 22, 2025 /PRNewswire/ -- MindHYVE.ai, Inc., and Khoja (Pirhai) Shia Isna Asheri Jamaat…

5 hours ago

Castle Connolly Names Dr. Meegan Gruber, MD, PhD a 2026 Exceptional Woman in Medicine; Recognition to Be Featured in New York Magazine

Board-certified plastic surgeon and surgeon-scientist honored for clinical excellence, leadership, and commitment to patient education. …

5 hours ago

Planning Time Off in 2026: Dr. Meegan Gruber, MD, PhD Releases a Recovery-Logistics Guide for Busy Professionals Considering Plastic Surgery

New "Recovery Logistics" checklist helps patients coordinate work, childcare, travel, and follow-up support-before they choose…

5 hours ago

How to Choose a Plastic Surgeon in 2026: Dr. Meegan Gruber, MD, PhD Releases a Tampa Bay Patient Safety Checklist

Board-certified plastic surgeon shares a practical, question-based guide to help patients verify credentials, facility standards,…

5 hours ago